Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NCT06208137 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

456

Enrollment

OTHER

Sponsor class

Conditions

Transplant-Related Disorder

Interventions

BEHAVIORAL: Health monitoring and regular return follow-up reminders

Sponsor

Institute of Hematology & Blood Diseases Hospital, China